文献速递小儿眼科与斜弱视眼整形与眼眶

FGF10/IGSF3变异与骨性先天性鼻泪管阻塞:综合征型与孤立型的基因型-表型研究

FGF10/IGSF3 Variants in Bony Congenital Nasolacrimal Duct Obstruction: A Genotype-Phenotype Study of Syndromic Versus Isolated Disease.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

该单中心回顾性病例研究对32名临床确诊的骨性先天性鼻泪管阻塞(bony CNLDO)患儿及亲属进行全外显子测序,发现8个新发FGF10变异和3个新发IGSF3变异。FGF10变异者均表现为泪腺和唾液腺发育不全综合征(ALSGs),而IGSF3变异者为孤立性骨性CNLDO且腺体形态正常。结论提示bony CNLDO主要为FGF10或IGSF3相关的单基因病,存在明确的基因型-表型关联。

要点

  • FGF10变异与综合征型多腺体发育不良相关,伴泪点异常和泪腺、腮腺、颌下腺发育不良。
  • IGSF3变异导致孤立性骨性CNLDO,腺体形态正常。
  • bony CNLDO主要为FGF10或IGSF3相关的单基因病,支持遗传诊断与咨询。

核心结论

  • 骨性先天性鼻泪管阻塞主要为涉及FGF10或IGSF3的单基因病,FGF10变异与综合征型多腺体发育不良相关,IGSF3变异导致孤立型。

研究设计与样本

  • 单中心回顾性病例研究纳入32名临床确诊的骨性CNLDO患儿及亲属,进行眼科和全身检查、眼眶CT、颌面部MRI及外周血全外显子测序。
  • 采用生物信息学工具预测变异致病性,并按ACMG指南进行分类。

主要发现

  • 全外显子测序识别出8个新发FGF10变异,包括6个错义突变、1个内含子剪接突变和1个包含FGF10基因的5p12染色体杂合缺失。
  • 所有FGF10变异患者均表现为泪腺和唾液腺发育不全综合征(ALSGs)表型,特征为骨性CNLDO、泪点异常及泪腺、腮腺和颌下腺发育不良。
  • 识别出3个新发IGSF3变异,包括2个错义突变和1个无义突变,携带者表现为孤立性骨性CNLDO且腺体形态正常。
  • 2例散发病例未发现可识别的致病性变异。

关键数值与推荐

  • FGF10变异:6个错义突变(c.598C>G、c.316T>G、c.395T>C、c.316T>C、c.327C>G、c.332T>G),1个内含子剪接突变(c.429+2T>A),1个5p12染色体杂合缺失。
  • IGSF3变异:2个错义突变(c.2872G>C、c.2531G>A),1个无义突变(c.2416G>T)。

临床怎么用

  • 对骨性CNLDO患儿,尤其伴泪点异常或多腺体发育不良者,应考虑FGF10/IGSF3基因检测以辅助遗传诊断和咨询。
  • FGF10变异提示需评估泪腺、腮腺和颌下腺等全身腺体异常;IGSF3变异者腺体形态正常,表型相对孤立。

局限性

  • 单中心回顾性研究,样本量有限(32名参与者,含6个家系和7例散发病例)。
  • 2例散发病例未发现致病性变异,提示可能存在其他未识别的遗传或非遗传因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to identify pathogenic variants associated with congenital bony nasolacrimal duct obstruction (bony CNLDO) and to clarify genotype-phenotype correlations. METHODS: In this single-center retrospective case study, children with clinically confirmed bony CNLDO and their relatives underwent detailed ophthalmic, systemic examinations, orbital computed tomography (CT), and maxillofacial magnetic resonance imaging (MRI). Whole-exome sequencing (WES) was performed on peripheral blood samples. Bioinformatics tools were utilized to predict variant pathogenicity, and classifications were performed according to the American College of Medical Genetics and Genomics (ACMG) guidelines. RESULTS: Thirty-two participants were included in this study, comprising six families and seven sporadic cases. WES identified 8 novel FGF10 variants, including 6 missense mutations (c.598C>G, c.316T>G, c.395T>C, c.316T>C, c.327C>G, and c.332T>G), one intronic splicing mutation (c.429+2T>A), and one heterozygous deletion at chromosome 5p12 encompassing the FGF10 gene. Two sporadic cases had no identifiable pathogenic variants. All patients with FGF10 variants exhibited syndromic aplasia of lacrimal and salivary glands (ALSGs) phenotype characterized by bony CNLDO, punctal anomalies, and hypoplasia of lacrimal, parotid, and submandibular glands. Three novel IGSF3 variants were also identified including two missense mutations (c.2872G>C and c.2531G>A) and one nonsense mutation (c.2416G>T). In contrast, individuals carrying IGSF3 variants showed isolated bony CNLDO with normal glandular morphology. CONCLUSIONS: Bony CNLDO is predominantly a monogenic disorder involving FGF10 or IGSF3. FGF10 mutations are associated with syndromic, multi-gland hypoplasia, whereas IGSF3 mutations result in isolated bony CNLDO. These findings enhance understanding of the genetic heterogeneity and genotype-phenotype correlations underlying bony CNLDO, with real-world implications for genetic diagnosis and counseling.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Li Y, Feng ZX, Cui Y, et al. FGF10/IGSF3 Variants in Bony Congenital Nasolacrimal Duct Obstruction: A Genotype-Phenotype Study of Syndromic Versus Isolated Disease. Invest Ophthalmol Vis Sci. 2025. PMID: 41533940. doi:10.1167/iovs.66.15.69

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。